KLARICID Side Effects

7023402-6 | Dermatitis Exfoliative, Dyspnoea, Pyrexia, Swelling
on Sep 21, 2010 Male patient from JAPAN , 44 years of age, was diagnosed with helicobacter infection, gastric ulcer, hypertension, spinal osteoarthritis and was treated with Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, dyspnoea, pyrexia, swelling. Klaricid dosage: . During the same period patient was treated with PASETOCIN (View Pasetocin Review and Pasetocin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LONGERIL (View Longeril Review and Longeril Label ), LIMAPROST ALFADEX (View Limaprost Alfadex Review and Limaprost Alfadex Label ), COMESGEN (View Comesgen Review and Comesgen Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

7021027-X | Renal Failure Acute
Patient was taking Klaricid (View Usage). Patient had the following side effects: renal failure acute on Sep 20, 2010 from GREECE Additional patient health information: Female patient , 75 years of age, was diagnosed with respiratory tract infection and. Klaricid dosage: . Patient was hospitalized.

7019249-7 | Acidosis, Cheyne-stokes Respiration, Disseminated Intravascular Coagulation, Hyponatraemia, Platelet Count Decreased, Shock, Staphylococcal Sepsis
Adverse event was reported on Sep 21, 2010 by a Female patient taking Klaricid (View Usage) (Dosage: ) was diagnosed with pemphigoid, bacterial infection (What is bacterial infection?), prophylaxis, dialysis (What is dialysis?), thrombosis prophylaxis, prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis and. Location: JAPAN , weighting 105.8 lb, After Klaricid was administered, patient had the following side effects: acidosis, cheyne-stokes respiration, disseminated intravascular coagulation, hyponatraemia, platelet count decreased, shock, staphylococcal sepsis. During the same period patient was treated with HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), PREDONINE (5mg-45mg/day: Taper Dosage) (View Predonine Review and Predonine Label ), GASTER D (View Gaster D Review and Gaster D Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), ONEALFA (View Onealfa Review and Onealfa Label ). Patient was hospitalized and became disabled.

7005160-4 | Dermatitis Exfoliative, Dyspnoea, Pyrexia, Swelling
on Sep 14, 2010 Male patient from JAPAN , 44 years of age, was diagnosed with helicobacter infection, gastric ulcer, hypertension, spinal osteoarthritis and was treated with Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, dyspnoea, pyrexia, swelling. Klaricid dosage: . During the same period patient was treated with PASETOCIN (View Pasetocin Review and Pasetocin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LONGERIL (View Longeril Review and Longeril Label ), LIMAPROST ALFADEX (View Limaprost Alfadex Review and Limaprost Alfadex Label ), COMESGEN (View Comesgen Review and Comesgen Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ). Patient was hospitalized.


6961811-1 | Acidosis, Cheyne-stokes Respiration, Disseminated Intravascular Coagulation, Hyponatraemia, Platelet Count Decreased, Shock, Staphylococcal Sepsis
on Aug 27, 2010 Female patient from JAPAN , weighting 105.8 lb, was diagnosed with pemphigoid, bacterial infection (What is bacterial infection?), prophylaxis, dialysis (What is dialysis?), thrombosis prophylaxis, prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis and was treated with Klaricid (View Usage). Patient had the following side effects: acidosis, cheyne-stokes respiration, disseminated intravascular coagulation, hyponatraemia, platelet count decreased, shock, staphylococcal sepsis. Klaricid dosage: . During the same period patient was treated with HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), PREDONINE (5mg-45mg/day: Taper Dosage) (View Predonine Review and Predonine Label ), GASTER D (View Gaster D Review and Gaster D Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), ONEALFA (View Onealfa Review and Onealfa Label ). Patient was hospitalized and became disabled.

6928542-5 | Hypoglycaemic Coma
Patient was taking Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: hypoglycaemic coma on Aug 04, 2010 from JAPAN Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with helicobacter infection, type 2 diabetes mellitus, hypertension, gastric ulcer and. Klaricid dosage: . During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ACTOS (View Actos Review and Actos Label ), BASEN (View Basen Review and Basen Label ), TAKEPRON (View Takepron Review and Takepron Label ), PASETOCIN (View Pasetocin Review and Pasetocin Label ).

6915479-0 | Syncope, Torsade De Pointes
Adverse event was reported on Jul 30, 2010 by a Male patient taking Klaricid (View Usage) (Dosage: ) was diagnosed with nasopharyngitis, atrial fibrillation (What is atrial fibrillation?), hypertension, insomnia, diabetes mellitus and. Location: JAPAN , 69 years of age, weighting 132.9 lb, Patient experienced the following unwanted or unexpected effects: syncope, torsade de pointes. During the same period patient was treated with BEPRIDIL (View Bepridil Review and Bepridil Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), PARAMIDIN (View Paramidin Review and Paramidin Label ), LENDORMIN D (View Lendormin D Review and Lendormin D Label ), PENFILL N (View Penfill N Review and Penfill N Label ), BISOLVON (View Bisolvon Review and Bisolvon Label ). Patient was hospitalized.

6911723-4 | Disseminated Intravascular Coagulation, Heparin-induced Thrombocytopenia, Malaise, Platelet Count Decreased, Pyrexia, Shock, Staphylococcal Sepsis
on Jul 29, 2010 Female patient from JAPAN , weighting 105.8 lb, was diagnosed with pemphigoid, bacterial infection (What is bacterial infection?), prophylaxis, dialysis (What is dialysis?), thrombosis prophylaxis, prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis and was treated with Klaricid (View Usage). Patient had the following side effects: disseminated intravascular coagulation, heparin-induced thrombocytopenia, malaise, platelet count decreased, pyrexia, shock, staphylococcal sepsis. Klaricid dosage: . During the same period patient was treated with HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), PREDONINE (5mg-45mg/day: Taper Dosage) (View Predonine Review and Predonine Label ), GASTER D (View Gaster D Review and Gaster D Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), ONEALFA (View Onealfa Review and Onealfa Label ).

6863392-X | Platelet Count Decreased
on Jul 15, 2010 Female patient from JAPAN , 83 years of age, was diagnosed with pemphigoid and was treated with Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: platelet count decreased. Klaricid dosage: . During the same period patient was treated with HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6839950-5 | Syncope, Torsade De Pointes
Patient was taking Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: syncope, torsade de pointes on Jul 05, 2010 from JAPAN Additional patient health information: Male patient , 64 years of age, weighting 103.6 lb, . Klaricid dosage: . During the same period patient was treated with BEPRIDIL (View Bepridil Review and Bepridil Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BETA BLOCKER (View Beta-blocker Review and Beta-blocker Label ), ANGIOTENSIN CONVERTING ENZYME INHIBITOR (View Angiotensin Converting Enzyme Inhibitor Review and Angiotensin Converting Enzyme Inhibitor Label ).

6784943-X | Dysgeusia, Headache, Mouth Ulceration, Nausea
Adverse event was reported on Jun 15, 2010 by a Female patient taking Klaricid (View Usage) (Dosage: ) was diagnosed with atypical mycobacterial infection, mycobacterium avium complex infection and. Location: UNITED KINGDOM , 44 years of age, weighting 157.0 lb, Patient had the following side effects: dysgeusia, headache (What is headache?), mouth ulceration, nausea (What is nausea?). During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ).

6774115-7 | Aphasia, Delirium, Illusion, Insomnia, Panic Reaction, Personality Disorder
on Jun 09, 2010 Male patient from GREECE , 57 years of age, weighting 198.4 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: aphasia (What is aphasia?), delirium, illusion, insomnia, panic reaction, personality disorder (What is personality disorder?). Klaricid dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ).

6767478-X | Decreased Appetite, Dysgeusia, Respiratory Tract Infection, Weight Decreased
on Jun 04, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with respiratory tract infection, idiopathic pulmonary fibrosis and was treated with Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, dysgeusia, respiratory tract infection, weight decreased. Klaricid dosage: . During the same period patient was treated with PIRFENIDONE (View Pirfenidone Review and Pirfenidone Label ), COTRIM (View Cotrim Review and Cotrim Label ).

6761130-2 | Aphasia, Delirium, Illusion, Insomnia, Panic Reaction, Personality Disorder
Patient was taking Klaricid (View Usage). Patient had the following side effects: aphasia (What is aphasia?), delirium, illusion, insomnia, panic reaction, personality disorder (What is personality disorder?) on Jun 03, 2010 from GREECE Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with pneumonia (What is pneumonia?) and. Klaricid dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ).

6756773-6 | Decreased Appetite, Dysgeusia, Respiratory Tract Infection, Weight Decreased
Adverse event was reported on May 31, 2010 by a Male patient taking Klaricid (View Usage) (Dosage: ) was diagnosed with respiratory tract infection, idiopathic pulmonary fibrosis and. Location: JAPAN , 74 years of age, After Klaricid was administered, patient had the following side effects: decreased appetite, dysgeusia, respiratory tract infection, weight decreased. During the same period patient was treated with PIRFENIDONE (View Pirfenidone Review and Pirfenidone Label ), COTRIM (View Cotrim Review and Cotrim Label ).

6751373-6 | Hypoglycaemic Coma
on May 24, 2010 Male patient from JAPAN , weighting 132.3 lb, was diagnosed with helicobacter infection, type 2 diabetes mellitus, hypertension, gastric ulcer and was treated with Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemic coma. Klaricid dosage: . During the same period patient was treated with GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ACTOS (View Actos Review and Actos Label ), BASEN (View Basen Review and Basen Label ), TAKEPRON (View Takepron Review and Takepron Label ), PASETOCIN (View Pasetocin Review and Pasetocin Label ).

6677912-1 | Anaphylactic Shock, Circulatory Collapse, Urticaria
on Apr 02, 2010 Female patient from JAPAN , weighting 152.1 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Klaricid (View Usage). Patient had the following side effects: anaphylactic shock, circulatory collapse, urticaria. Klaricid dosage: . During the same period patient was treated with HUSTAGIN (View Hustagin Review and Hustagin Label ), ELIETEN (View Elieten Review and Elieten Label ), NICHOLASE (View Nicholase Review and Nicholase Label ). Patient was hospitalized.

6594927-2 | Anaphylactic Reaction, Lip Swelling, Paraesthesia Oral
Patient was taking Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: anaphylactic reaction, lip swelling, paraesthesia oral on Feb 12, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 52 years of age, weighting 127.9 lb, was diagnosed with lower respiratory tract infection and. Klaricid dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), SPIRIVA (View Spiriva Review and Spiriva Label ).

6552150-1 | Acute Myocardial Infarction, Bile Duct Obstruction, Bradyarrhythmia, Dialysis, Disseminated Intravascular Coagulation, Enterococcal Infection, Haemodialysis, Hyperbilirubinaemia, Hypersensitivity
Adverse event was reported on Jan 21, 2010 by a Male patient taking Klaricid (View Usage) (Dosage: ) was diagnosed with pyrexia, hairy cell leukaemia, prophylaxis, hypertension, hyperlipidaemia, infection prophylaxis, tumour lysis syndrome and. Location: UNITED KINGDOM , weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, bile duct obstruction, bradyarrhythmia, dialysis (What is dialysis?), disseminated intravascular coagulation, enterococcal infection, haemodialysis, hyperbilirubinaemia, hypersensitivity. During the same period patient was treated with LITAK (View Litak Review and Litak Label ), ACICLOVIR (View Aciclovir Review and Aciclovir Label ), CO TRIMOXAZOLE (View Co-trimoxazole Review and Co-trimoxazole Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6513189-5 | Blood Creatine Phosphokinase Increased, Muscle Tightness, Myalgia, Pain In Extremity
on Dec 17, 2009 Female patient from UNITED KINGDOM , 24 years of age, weighting 154.3 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Klaricid (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, muscle tightness, myalgia, pain in extremity. Klaricid dosage: . Patient was hospitalized.

6501979-4 | Rash Pruritic
on Dec 09, 2009 Female patient from UNITED STATES , 34 years of age, was diagnosed with respiratory tract infection and was treated with Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: rash pruritic. Klaricid dosage: . During the same period patient was treated with DEXA RHINASPRAY (Spray) (View Dexa Rhinaspray Review and Dexa Rhinaspray Label ). Patient was hospitalized.

6481398-X | Urinary Retention
Patient was taking Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: urinary retention on Dec 03, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 82 years of age, weighting 127.9 lb, was diagnosed with influenza and. Klaricid dosage: 250mg/5ml. During the same period patient was treated with MELITRACEN (View Melitracen Review and Melitracen Label ), FLUPENTIXOL (View Flupentixol Review and Flupentixol Label ), FRUMIL (View Frumil Review and Frumil Label ).

6480160-1 | Rash Pruritic
Adverse event was reported on Nov 28, 2009 by a Female patient taking Klaricid (View Usage) (Dosage: ) was diagnosed with respiratory tract infection and. Location: UNITED STATES , 34 years of age, Patient had the following side effects: rash pruritic. During the same period patient was treated with DEXA RHINASPRAY (Spray) (View Dexa Rhinaspray Review and Dexa Rhinaspray Label ). Patient was hospitalized.

6474336-7 | Rash, Vasculitis
on Nov 24, 2009 Female patient from UNITED KINGDOM , 51 years of age, was diagnosed with tracheitis, arthralgia, lower respiratory tract infection and was treated with Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: rash (What is rash?), vasculitis (What is vasculitis?). Klaricid dosage: . During the same period patient was treated with DICLOFENAC (View Diclofenac Review and Diclofenac Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

6457923-1 | Deafness Neurosensory
on Nov 18, 2009 Female patient from GREECE , 28 years of age, was diagnosed with upper respiratory tract infection and was treated with Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: deafness neurosensory. Klaricid dosage: . Patient was hospitalized.

6440467-0 | Eosinophilic Pneumonia
Patient was taking Klaricid (View Usage). Patient had the following side effects: eosinophilic pneumonia on Nov 05, 2009 from JAPAN Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with pyrexia, productive cough, bronchitis (What is bronchitis?), rhinorrhoea, oropharyngeal pain and. Klaricid dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ). Patient was hospitalized.

6427384-7 | Eosinophilic Pneumonia
Adverse event was reported on Oct 30, 2009 by a Male patient taking Klaricid (View Usage) (Dosage: ) was diagnosed with pyrexia, productive cough, bronchitis (What is bronchitis?), rhinorrhoea, oropharyngeal pain and. Location: JAPAN , weighting 198.4 lb, After Klaricid was administered, patient had the following side effects: eosinophilic pneumonia. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6423352-X | Urinary Retention
on Oct 23, 2009 Female patient from UNITED KINGDOM , 82 years of age, was treated with Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: urinary retention. Klaricid dosage: . During the same period patient was treated with MELITRACEN (View Melitracen Review and Melitracen Label ), FLUPENTIXOL (View Flupentixol Review and Flupentixol Label ).

6420580-4 | Dyspnoea, Exercise Tolerance Decreased, Productive Cough, Sputum Discoloured
on Oct 26, 2009 Female patient from UNITED KINGDOM , 60 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Klaricid (View Usage). Patient had the following side effects: dyspnoea, exercise tolerance decreased, productive cough, sputum discoloured. Klaricid dosage: . During the same period patient was treated with NICOTINE (View Nicotine Review and Nicotine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NEBULISER (View Nebuliser Review and Nebuliser Label ). Patient was hospitalized.

6409808-4 | Dizziness, Dyspnoea
Patient was taking Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: dizziness (What is dizziness?), dyspnoea on Oct 13, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 78 years of age, was diagnosed with lung infection and. Klaricid dosage: 2 Tablets Per Day.

6383282-9 | Eosinophilic Pneumonia
Adverse event was reported on Sep 24, 2009 by a Male patient taking Klaricid (View Usage) (Dosage: ) was diagnosed with pyrexia, productive cough, bronchitis (What is bronchitis?), rhinorrhoea, oropharyngeal pain and. Location: JAPAN , weighting 198.4 lb, Patient experienced the following unwanted or unexpected effects: eosinophilic pneumonia. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6345416-1 | Eosinophilic Pneumonia
on Sep 02, 2009 Male patient from JAPAN , 52 years of age, was diagnosed with pyrexia, productive cough, rhinorrhoea, oropharyngeal pain and was treated with Klaricid (View Usage). Patient had the following side effects: eosinophilic pneumonia. Klaricid dosage: Not Reported. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ). Patient was hospitalized.

6338350-4 | Eosinophilic Pneumonia
on Aug 24, 2009 Male patient from JAPAN , 52 years of age, was diagnosed with pyrexia, productive cough and was treated with Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: eosinophilic pneumonia. Klaricid dosage: Not Reported. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ). Patient was hospitalized.

6313356-X | Pneumonia, Pulmonary Alveolar Haemorrhage, Respiratory Failure
Patient was taking Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), pulmonary alveolar haemorrhage, respiratory failure on Aug 13, 2009 from BRAZIL Additional patient health information: Male patient , 24 years of age, . Klaricid dosage: . During the same period patient was treated with OSELTAMIVIR (View Oseltamivir Review and Oseltamivir Label ), IMIPENEM (View Imipenem Review and Imipenem Label ), TAZOCIN (View Tazocin Review and Tazocin Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ). Patient was hospitalized.

6298357-2 | Interstitial Lung Disease
Adverse event was reported on Jul 28, 2009 by a Male patient taking Klaricid (View Usage) (Dosage: Not Reported, Not Reported) . Location: JAPAN , 64 years of age, Patient had the following side effects: interstitial lung disease. During the same period patient was treated with PA (View Pa Review and Pa Label ), DEXTROMETHORPHAN HYDROBROMIDE (View Dextromethorphan Hydrobromide Review and Dextromethorphan Hydrobromide Label ). Patient was hospitalized.

6284917-1 | Cardiac Failure
on Jul 23, 2009 Female patient from JAPAN , weighting 74.96 lb, was diagnosed with productive cough, bronchial secretion retention and was treated with Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: cardiac failure. Klaricid dosage: . During the same period patient was treated with ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ). Patient was hospitalized.

6284810-4 | Abdominal Mass, Alopecia, Atypical Mycobacterial Infection, Decreased Appetite, Disseminated Intravascular Coagulation, Dysgeusia, Histiocytosis Haematophagic
on Jul 17, 2009 Female patient from JAPAN , weighting 99.21 lb, was diagnosed with mycobacterial infection, abdominal mass, rheumatoid arthritis (What is rheumatoid arthritis?), gastritis and was treated with Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal mass, alopecia, atypical mycobacterial infection, decreased appetite, disseminated intravascular coagulation, dysgeusia, histiocytosis haematophagic. Klaricid dosage: 200 Mg Tablets. During the same period patient was treated with METHOTREXATE (4mg/ 1week) (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

6269903-X | Abdominal Mass, Alopecia, Atypical Mycobacterial Infection, Decreased Appetite, Disseminated Intravascular Coagulation, Dysgeusia, Histiocytosis Haematophagic
Patient was taking Klaricid (View Usage). Patient had the following side effects: abdominal mass, alopecia, atypical mycobacterial infection, decreased appetite, disseminated intravascular coagulation, dysgeusia, histiocytosis haematophagic on Jul 09, 2009 from JAPAN Additional patient health information: Female patient , weighting 99.21 lb, was diagnosed with mycobacterial infection, abdominal mass, rheumatoid arthritis (What is rheumatoid arthritis?) and. Klaricid dosage: 200 Mg Tablets. During the same period patient was treated with METHOTREXATE (4mg/ 1week) (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6257337-3 | Abdominal Mass, Alopecia, Atypical Mycobacterial Infection, Decreased Appetite, Disseminated Intravascular Coagulation, Dysgeusia, Histiocytosis Haematophagic
Adverse event was reported on Jun 26, 2009 by a Female patient taking Klaricid (View Usage) (Dosage: 200 Mg Tablets) was diagnosed with mycobacterial infection, abdominal mass, rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , weighting 99.21 lb, After Klaricid was administered, patient had the following side effects: abdominal mass, alopecia, atypical mycobacterial infection, decreased appetite, disseminated intravascular coagulation, dysgeusia, histiocytosis haematophagic. During the same period patient was treated with METHOTREXATE (8mg Weekly) (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6245120-4 | Cardiac Failure
on Jun 15, 2009 Female patient from JAPAN , weighting 74.96 lb, was diagnosed with bronchial secretion retention and was treated with Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure. Klaricid dosage: . During the same period patient was treated with ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ).

6230204-7 | Leukocytoclastic Vasculitis
on Jun 09, 2009 Male patient from JAPAN , 79 years of age, was diagnosed with bronchitis (What is bronchitis?), allergy test positive and was treated with Klaricid (View Usage). Patient had the following side effects: leukocytoclastic vasculitis. Klaricid dosage: . During the same period patient was treated with THEOPHYLLINE (View Theophylline Review and Theophylline Label ), L CARBOCYSTINE (View L-carbocystine Review and L-carbocystine Label ). Patient was hospitalized.

6212969-3 | Leukocytoclastic Vasculitis
Patient was taking Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: leukocytoclastic vasculitis on May 27, 2009 from JAPAN Additional patient health information: Male patient , 79 years of age, was diagnosed with bronchitis (What is bronchitis?), allergy test positive and. Klaricid dosage: . During the same period patient was treated with THEOPHYLLINE (View Theophylline Review and Theophylline Label ), L CARBOCISTEINE (View L-carbocisteine Review and L-carbocisteine Label ), TULOBUTEROL (View Tulobuterol Review and Tulobuterol Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), LISINOPRIL HYDRATE (View Lisinopril Hydrate Review and Lisinopril Hydrate Label ), AMBROXOL HYDROCHLORIDE (View Ambroxol Hydrochloride Review and Ambroxol Hydrochloride Label ). Patient was hospitalized.

6210851-9 | Dyspnoea, Exercise Tolerance Decreased, Productive Cough
Adverse event was reported on May 25, 2009 by a Female patient taking Klaricid (View Usage) (Dosage: ) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED KINGDOM , 68 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, exercise tolerance decreased, productive cough. During the same period patient was treated with NICOTINE (View Nicotine Review and Nicotine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NEBULISER (View Nebuliser Review and Nebuliser Label ). Patient was hospitalized.

6184791-8 | Anaphylactic Shock, Urticaria
on May 07, 2009 Female patient from JAPAN , weighting 152.1 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Klaricid (View Usage). Patient had the following side effects: anaphylactic shock, urticaria. Klaricid dosage: . During the same period patient was treated with HUSTAGIN (View Hustagin Review and Hustagin Label ), ELIETEN (View Elieten Review and Elieten Label ), NICHOLASE (View Nicholase Review and Nicholase Label ). Patient was hospitalized.

6176375-2 | Hypoglycaemia, Loss Of Consciousness
on Apr 24, 2009 Male patient from JAPAN , weighting 101.4 lb, was diagnosed with bronchitis (What is bronchitis?), diabetes mellitus, dementia (What is dementia?), asthma (What is asthma?), cerebral infarction, prophylaxis, constipation (What is constipation?) and was treated with Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: hypoglycaemia, loss of consciousness. Klaricid dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), FASTIC (View Fastic Review and Fastic Label ), ARICEPT (View Aricept Review and Aricept Label ), SINGULAIR (View Singulair Review and Singulair Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MAGLAX (View Maglax Review and Maglax Label ), YOKUKAN SAN (View Yokukan-san Review and Yokukan-san Label ). Patient was hospitalized.

6175351-3 | Abdominal Mass, Alopecia, Anorexia, Dysgeusia, Nausea, Pancytopenia
Patient was taking Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal mass, alopecia, anorexia, dysgeusia, nausea (What is nausea?), pancytopenia on Apr 27, 2009 from JAPAN Additional patient health information: Female patient , weighting 99.21 lb, was diagnosed with mycobacterial infection, abdominal mass, rheumatoid arthritis (What is rheumatoid arthritis?), gastritis, osteoporosis (What is osteoporosis?) and. Klaricid dosage: . During the same period patient was treated with METHOTREXATE (8mg Weekly) (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ). Patient was hospitalized.

6166140-4 | Arthralgia, Back Pain, Multi-organ Failure, Muscular Weakness, Renal Failure, Rhabdomyolysis
Adverse event was reported on Apr 15, 2009 by a Female patient taking Klaricid (View Usage) (Dosage: ) was diagnosed with bronchitis (What is bronchitis?), hyperlipidaemia, respiratory disorder, hypertension and. Location: GREECE , weighting 121.3 lb, Patient had the following side effects: arthralgia, back pain (What is back pain?), multi-organ failure, muscular weakness, renal failure, rhabdomyolysis. During the same period patient was treated with VASSOR (View Vassor Review and Vassor Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ALVEFCO (View Alvefco Review and Alvefco Label ), DILATREND (View Dilatrend Review and Dilatrend Label ), NITRONG (Patch) (View Nitrong Review and Nitrong Label ). Patient was hospitalized.

6164432-6 | Hypoglycaemia, Loss Of Consciousness
on Apr 14, 2009 Male patient from JAPAN , weighting 101.4 lb, was diagnosed with bronchitis (What is bronchitis?), diabetes mellitus, dementia (What is dementia?), asthma (What is asthma?), cerebral infarction, prophylaxis, constipation (What is constipation?) and was treated with Klaricid (View Usage). After Klaricid was administered, patient had the following side effects: hypoglycaemia, loss of consciousness. Klaricid dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), FASTIC (View Fastic Review and Fastic Label ), ARICEPT (View Aricept Review and Aricept Label ), SINGULAIR (View Singulair Review and Singulair Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MAGLAX (View Maglax Review and Maglax Label ), YOKUKAN SAN (View Yokukan-san Review and Yokukan-san Label ). Patient was hospitalized.

6159206-6 | Abdominal Mass, Alopecia, Anorexia, Dysgeusia, Nausea, Pancytopenia
on Apr 07, 2009 Female patient from JAPAN , weighting 99.21 lb, was diagnosed with mycobacterium avium complex immune restoration disease, abdominal mass, rheumatoid arthritis (What is rheumatoid arthritis?), gastritis, osteoporosis (What is osteoporosis?) and was treated with Klaricid (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal mass, alopecia, anorexia, dysgeusia, nausea (What is nausea?), pancytopenia. Klaricid dosage: . During the same period patient was treated with METHOTREXATE (8mg Weekly) (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ). Patient was hospitalized.

6157661-9 | Multi-organ Failure, Renal Failure, Rhabdomyolysis
Patient was taking Klaricid (View Usage). Patient had the following side effects: multi-organ failure, renal failure, rhabdomyolysis on Apr 07, 2009 from GREECE Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with bronchitis (What is bronchitis?), hyperlipidaemia, respiratory disorder, hypertension and. Klaricid dosage: . During the same period patient was treated with VASSOR (View Vassor Review and Vassor Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ALVEFCO (View Alvefco Review and Alvefco Label ), DILATREND (View Dilatrend Review and Dilatrend Label ), NITRONG (Patch) (View Nitrong Review and Nitrong Label ). Patient was hospitalized.